JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3476
8x8 Inc
EGHT
$329M
| $1.77M | ﹤0.01% |
344,542
+123,539
| +56% | +$1.03M |
2015 Q1
29 quarters
|
|
|
AUTL
3477
Autolus Therapeutics
AUTL
$474M
| $1.77M | ﹤0.01% |
626,519
-173,039
| -22% | -$527K |
2019 Q4
10 quarters
|
|
3478
LSB Industries
LXU
$710M
| $1.77M | ﹤0.01% |
127,850
+29,661
| +30% | +$592K |
2016 Q4
22 quarters
|
|
3479
Manitowoc
MTW
$837M
| $1.77M | ﹤0.01% |
168,116
-358,409
| -68% | -$4.49M |
2015 Q3
27 quarters
|
|
3480
Appian
APPN
$2.63B
| $1.77M | ﹤0.01% |
37,318
+6,242
| +20% | +$314K |
2017 Q2
20 quarters
|
|
3481
Designer Brands
DBI
$310M
| $1.77M | ﹤0.01% |
135,349
-121,490
| -47% | -$1.75M |
2015 Q1
29 quarters
|
|
|
SWI
3482
DELISTED
SolarWinds Corporation Common Stock
SWI
| $1.76M | ﹤0.01% |
172,041
+95,019
| +123% | +$1.13M |
2019 Q1
13 quarters
|
|
3483
Nokia
NOK
$59.3B
| $1.76M | ﹤0.01% |
380,985
-5,034,205
| -93% | -$25.1M |
2013 Q2
36 quarters
|
|
3484
Immatics
IMTX
$1.16B
| $1.75M | ﹤0.01% |
201,521
-1,119
| -0.6% | -$8.85K |
2021 Q1
5 quarters
|
|
3485
SkinHealth Systems
SKIN
$82M
| $1.75M | ﹤0.01% |
136,274
+26,440
| +24% | +$354K |
2020 Q4
6 quarters
|
|
|
LBC
3486
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $1.75M | ﹤0.01% |
133,752
-91,818
| -41% | -$1.22M |
2018 Q1
17 quarters
|
|
3487
Invesco Senior Income Trust
VVR
$445M
| $1.75M | ﹤0.01% |
448,662
-45,822
| -9% | -$184K |
2013 Q2
36 quarters
|
|
3488
Clearfield
CLFD
$455M
| $1.74M | ﹤0.01% |
28,081
+17,724
| +171% | +$1.04M |
2017 Q4
18 quarters
|
|
3489
PUT
Alnylam Pharmaceuticals
ALNY
$29.4B
| $1.74M | ﹤0.01% |
11,900
+300
| +3% | +$42.6K |
2021 Q4
2 quarters
|
|
3490
Invesco S&P SmallCap Health Care ETF
PSCH
$179M
| $1.73M | ﹤0.01% |
37,962
-153
| -0.4% | -$7.29K |
2021 Q1
5 quarters
|
|
3491
CALL
Check Point Software Technologies
CHKP
$13.3B
| $1.73M | ﹤0.01% |
+14,200
| New | +$1.82M |
2022 Q2
0 quarters
|
|
3492
PUT
Ryder
R
$9.1B
| $1.73M | ﹤0.01% |
+24,300
| New | +$1.78M |
2022 Q2
0 quarters
|
|
3493
PUT
Aon
AON
$57.2B
| $1.73M | ﹤0.01% |
6,400
+2,900
| +83% | +$834K |
2022 Q1
1 quarter
|
|
3494
DXP Enterprises
DXPE
$3.01B
| $1.72M | ﹤0.01% |
56,138
+8,440
| +18% | +$232K |
2013 Q2
36 quarters
|
|
3495
Brookfield Renewable
BEP
$8.51B
| $1.72M | ﹤0.01% |
49,366
+23,306
| +89% | +$839K |
2020 Q2
8 quarters
|
|
3496
iShares US Financials ETF
IYF
$3.92B
| $1.72M | ﹤0.01% |
24,545
-451
| -2% | -$34.4K |
2013 Q2
36 quarters
|
|
3497
Sierra Bancorp
BSRR
$515M
| $1.72M | ﹤0.01% |
78,982
+51,044
| +183% | +$1.14M |
2013 Q2
36 quarters
|
|
3498
Bilibili
BILI
$5.95B
| $1.72M | ﹤0.01% |
67,018
-831,792
| -93% | -$20M |
2018 Q1
17 quarters
|
|
|
MRO
3499
PUT
DELISTED
Marathon Oil Corporation
MRO
| $1.71M | ﹤0.01% |
76,100
+21,200
| +39% | +$567K |
2022 Q1
1 quarter
|
|
|
TWOU
3500
DELISTED
2U Inc
TWOU
| $1.71M | ﹤0.01% |
5,443
+77
| +1% | +$23.8K |
2014 Q2
32 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.